04312nam 2200541Ia 450 991078989820332120220525011458.01-61942-063-5(CKB)2670000000135205(EBL)3017783(SSID)ssj0000686753(PQKBManifestationID)12198992(PQKBTitleCode)TC0000686753(PQKBWorkID)10734369(PQKB)10394603(MiAaPQ)EBC3017783(Au-PeEL)EBL3017783(CaPaEBR)ebr10654754(OCoLC)923653523(EXLCZ)99267000000013520520111206d2011 uy 0engur|n|---|||||txtccrAcute kidney injury[electronic resource] causes, diagnosis, and treatments /Jonathan D. Mendoza, editorNew York Nova Biomedical/Nova Science Publishersc20111 online resource (200 p.)Nephrology research and clinical developmentsDescription based upon print version of record.1-61209-790-1 Includes bibliographical references and index.Contents -- Preface -- How to Define and Classify Acute Kidney Injury (AKI): The "Risk Injury Failure Loss of Kidney Function End-Stage Kidney Disease" (RIFLE) and "Acute Kidney Injury Network" (AKIN) Classifications -- Abstract -- Introduction -- The Risk Injury Failure Loss of Kidney Function End-Stage Kidney Disease (RIFLE) Classification -- Validation of the RIFLE Criteria -- Hospitalized Patients -- ICU Patients -- Patients Undergoing Cardiac Surgery Patients Undergoing Aortic Arch Surgery -- Patients Undergoing Abdominal Aortic Surgery -- Chirrotic Patients -- Patients Submitted to Hepatic Transplantation -- Septic Patients -- Burn Patients -- Critically Ill Human Immunodeficiency Virus Infected Patients -- Trauma Patients -- Patients Receiving Hematopoietic Stem Cell Transplantation -- Strengths and Weaknesses of the RIFLE Classification -- Strengths of the RIFLE Classification -- Weaknesses of the RIFLE Classification -- The Acute Kidney Injury Network (AKIN) classification Strengths and Weaknesses of the AKIN Classification -- Strengths of the AKIN Classification -- Weaknesses of the AKIN Classification -- Which Classification Should We Use in Clinical Practice? -- References -- Acute Renal Failure in the Newborn (NB) -- Abstract -- Introduction -- Characteristics of the Kidney in the Newborn -- Acute Renal Impairment in Newborns -- Physiopathology -- Definition of AKI -- Diagnosis of AKI: Clinical and Laboratorial Aspects -- New Biomarkers -- Suggested Intervals for the Control of Renal Function Handling the IRA in the NB -- Prognosis of the NB with AKI -- Conclusion -- References -- Kidney Ischemia and Reperfusion Injury -- Abstract -- Kidney Ischemia and Reperfusion Injury -- Vascular Endothelial Cells -- Tubular Epithelial Cells -- Activation of Kidney Resident Cells and Kidney-Infiltrating Leukocytes -- T-Lymphocytes -- Increased Factors after IRI -- Adhesion Molecules -- Cytokines and Chemokines -- Hypoxia-Inducible Factor -- Toll-Like Receptors -- Changes in Renal Tissue after IRI FTY720 -- Modulates the Inflammatory Process after IRI (74) -- References -- Long-Term Prognostic Implication of Post-Angiographic Acute Kidney Injury and Hemodynamic Instability -- Abstract -- Introduction -- Post-Angiographic AKI -- Role of Hemodynamics in the Formation of Post-Angiographic AKI -- Lessons from Animal Models -- Role of Hemodynamics in the Incidence of Post-Angiographic AKI -- from the Clinical Points of Views -- Short-Term Prognosis of Post-Angiographic AKI -- Long-Term Prognosis and Post-Angiographic AKI: Role of Hemodynamics.Nephrology research and clinical developments series.Acute renal failureKidneysDiseasesAcute renal failure.KidneysDiseases.616.6/14Mendoza Jonathan D1584755MiAaPQMiAaPQMiAaPQBOOK9910789898203321Acute kidney injury3868720UNINA